Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00265304 · ClinicalTrials.gov registry record · Phase 2

A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee

A Phase 2 study, sponsored by IDEA.

Completed
Registry status
Phase 2
Development phase
550
Enrollment target

NCT00265304: Completed Phase 2 study, sponsored by IDEA.

NCT00265304 is a Phase 2 study that has completed, run by IDEA. The registered enrollment target is 550 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (314% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00265304, a Phase 2 study, has completed, sponsored by IDEA.

COMPLETED
Registry status
Phase 2
Development phase
550 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the long-term safety of IDEA-033 (an anti-inflammatory pain-relieving drug applied to the skin) in comparison to naproxen (an anti-inflammatory pain-relieving drug taken by mouth) for the treatment of osteoarthritis of both knees.

Interventions

  • DRUG Ketoprofen

Trial Details

FieldValue
Enrollment Target 550 participants
Start Date 2005-07
Phase Phase 2
IDEA

3 total trials

What the finished NCT00265304 record still lists

NCT00265304 is an interventional study that assigns participants to a tested intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (314% higher).

The record links to 0 conditions, and to 1 intervention - of which Ketoprofen is the first listed.

NCT00265304 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00265304 about?

NCT00265304 is a clinical study titled "A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee". The purpose of this study is to evaluate the long-term safety of IDEA-033 (an anti-inflammatory pain-relieving drug applied to the skin) in comparison to naproxen (an anti-inflammatory pain-relieving drug taken by mouth) for the treatment of osteoarthritis of both knees.

What is the current status of trial NCT00265304?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 550 participants. The study started on 2005-07.

What interventions are being tested in trial NCT00265304?

The interventions under investigation include: Ketoprofen (DRUG).

Who is sponsoring clinical trial NCT00265304?

This trial is sponsored by IDEA, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00265304's enrollment target sits among peer trials

550 60th of 2000 higher than 1,939 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01852448 · 550 participants

    Genetics of Insulin and Incretins in Cystic Fibrosis

  • NCT02995252 · 550 participants

    The HOPE Study: Characterizing Patients With Hepatitis B and C

  • NCT03474913 · 550 participants

    Upright MRI for Prostate Cancer Screening

  • NCT04761120 · 550 participants

    Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00265304, the US trial registry maintained by the National Library of Medicine. NCT00265304 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.